BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35149170)

  • 41. Emerging high-level ciprofloxacin-resistant Salmonella enterica serovar typhi haplotype H58 in travelers returning to the Republic of Korea from India.
    Shin E; Park J; Jeong HJ; Park AK; Na K; Lee H; Chun JH; Hwang KJ; Kim CJ; Kim J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009170. PubMed ID: 33651791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Designing a multi-epitope vaccine against Chlamydia pneumoniae by integrating the core proteomics, subtractive proteomics and reverse vaccinology-based immunoinformatics approaches.
    Noor F; Ahmad S; Saleem M; Alshaya H; Qasim M; Rehman A; Ehsan H; Talib N; Saleem H; Bin Jardan YA; Aslam S
    Comput Biol Med; 2022 Jun; 145():105507. PubMed ID: 35429833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering a Novel Bivalent Oral Vaccine against Enteric Fever.
    Soulier A; Prevosto C; Chol M; Deban L; Cranenburgh RM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33807097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple Introductions of Salmonella enterica Serovar Typhi H58 with Reduced Fluoroquinolone Susceptibility into Chile.
    Maes M; Dyson ZA; Higginson EE; Fernandez A; Araya P; Tennant SM; Baker S; Lagos R; Levine MM; Hormazabal JC; Dougan G
    Emerg Infect Dis; 2020 Nov; 26(11):2736-2740. PubMed ID: 33079054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salmonella Typhi acquires diverse plasmids from other Enterobacteriaceae to develop cephalosporin resistance.
    Jacob JJ; Pragasam AK; Vasudevan K; Veeraraghavan B; Kang G; John J; Nagvekar V; Mutreja A
    Genomics; 2021 Jul; 113(4):2171-2176. PubMed ID: 33965548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.
    Wong VK; Baker S; Pickard DJ; Parkhill J; Page AJ; Feasey NA; Kingsley RA; Thomson NR; Keane JA; Weill FX; Edwards DJ; Hawkey J; Harris SR; Mather AE; Cain AK; Hadfield J; Hart PJ; Thieu NT; Klemm EJ; Glinos DA; Breiman RF; Watson CH; Kariuki S; Gordon MA; Heyderman RS; Okoro C; Jacobs J; Lunguya O; Edmunds WJ; Msefula C; Chabalgoity JA; Kama M; Jenkins K; Dutta S; Marks F; Campos J; Thompson C; Obaro S; MacLennan CA; Dolecek C; Keddy KH; Smith AM; Parry CM; Karkey A; Mulholland EK; Campbell JI; Dongol S; Basnyat B; Dufour M; Bandaranayake D; Naseri TT; Singh SP; Hatta M; Newton P; Onsare RS; Isaia L; Dance D; Davong V; Thwaites G; Wijedoru L; Crump JA; De Pinna E; Nair S; Nilles EJ; Thanh DP; Turner P; Soeng S; Valcanis M; Powling J; Dimovski K; Hogg G; Farrar J; Holt KE; Dougan G
    Nat Genet; 2015 Jun; 47(6):632-9. PubMed ID: 25961941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reverse vaccinology approach for the identifications of potential vaccine candidates against Salmonella.
    Li J; Qiu J; Huang Z; Liu T; Pan J; Zhang Q; Liu Q
    Int J Med Microbiol; 2021 Jul; 311(5):151508. PubMed ID: 34182206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salmonella typhi: from a human pathogen to a vaccine vector.
    Zhang XL; Jeza VT; Pan Q
    Cell Mol Immunol; 2008 Apr; 5(2):91-7. PubMed ID: 18445338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salmonella Typhi genomics: envisaging the future of typhoid eradication.
    Yap KP; Thong KL
    Trop Med Int Health; 2017 Aug; 22(8):918-925. PubMed ID: 28544285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome-Wide Subtraction Analysis and Reverse Vaccinology to Detect Novel Drug Targets and Potential Vaccine Candidates Against Ehrlichia chaffeensis.
    Sabzi S; Shahbazi S; Noori Goodarzi N; Haririzadeh Jouriani F; Habibi M; Bolourchi N; Mirzaie A; Badmasti F
    Appl Biochem Biotechnol; 2023 Jan; 195(1):107-124. PubMed ID: 36053401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of novel putative immunogenic targets against Staphylococcus aureus using a reverse vaccinology strategy.
    Noori Goodarzi N; Bolourchi N; Fereshteh S; Soltani Shirazi A; Pourmand MR; Badmasti F
    Infect Genet Evol; 2021 Dec; 96():105149. PubMed ID: 34801756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning, sequencing, and in silico characterization of Omp 28 of Salmonella Typhi (strain MTCC 733) to develop r-DNA vaccine for typhoid fever.
    Saxena A; Tamuly S; Saxena MK
    J Nat Sci Biol Med; 2012 Jul; 3(2):133-8. PubMed ID: 23225974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compositional and Functional Differences in the Human Gut Microbiome Correlate with Clinical Outcome following Infection with Wild-Type Salmonella enterica Serovar Typhi.
    Zhang Y; Brady A; Jones C; Song Y; Darton TC; Jones C; Blohmke CJ; Pollard AJ; Magder LS; Fasano A; Sztein MB; Fraser CM
    mBio; 2018 May; 9(3):. PubMed ID: 29739901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012.
    Hendriksen RS; Leekitcharoenphon P; Lukjancenko O; Lukwesa-Musyani C; Tambatamba B; Mwaba J; Kalonda A; Nakazwe R; Kwenda G; Jensen JD; Svendsen CA; Dittmann KK; Kaas RS; Cavaco LM; Aarestrup FM; Hasman H; Mwansa JC
    J Clin Microbiol; 2015 Jan; 53(1):262-72. PubMed ID: 25392358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
    Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide screening of vaccine targets prioritization and reverse vaccinology aided design of peptides vaccine to enforce humoral immune response against Campylobacter jejuni.
    Zeb A; Ali SS; Azad AK; Safdar M; Anwar Z; Suleman M; Nizam-Uddin N; Khan A; Wei DQ
    Comput Biol Med; 2021 Jun; 133():104412. PubMed ID: 33934066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteome-wide mapping and reverse vaccinology-based B and T cell multi-epitope subunit vaccine designing for immune response reinforcement against
    Khan S; Ali SS; Zaheer I; Saleem S; Ziaullah ; Zaman N; Iqbal A; Suleman M; Wadood A; Rehman AU; Khan A; Khan A; Wei DQ
    J Biomol Struct Dyn; 2022 Feb; 40(2):833-847. PubMed ID: 32928063
    [No Abstract]   [Full Text] [Related]  

  • 59. Pan-Genome Reverse Vaccinology Approach for the Design of Multi-Epitope Vaccine Construct against
    Jalal K; Khan K; Ahmad D; Hayat A; Basharat Z; Abbas MN; Alghamdi S; Almehmadi M; Sahibzada MUK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884620
    [No Abstract]   [Full Text] [Related]  

  • 60. Genomic Investigation of
    Li X; Cao H; Chen JH; Ng YZ; Fung KK; Cheng VC; Ho PL
    Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.